Boston Translational LLC — Form D/A
Boston Translational LLC of Allston, MA, a company, filed a Form D amendment with the SEC on 2018-04-16. The offering totals $4.0M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-04-16
- Form: D/A
- Accession: 0001717227-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.8M
- Remaining: $2.2M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2017-09-07
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-294903
Issuer
- Name: Boston Translational LLC
- CIK: 0001717227
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 41 Haskell St, Allston, MA, 02134
- Phone: 619-405-6769
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Holzer | Director | Enfield, NH |
| Paul Holzer | Executive Officer | Enfield, NH |
| Krysta Moulton | Executive Officer | Arlington, VA |
| Paul Holzer | Promoter | Enfield, NH |
| Krysta Nichol Moulton | Executive Officer | SEABROOK, NH |
Other filings by this issuer (1)
More